Bingfeng Han
Impact in
Papers in
- Health 9
- Vaccine Coverage and Hesitancy 9
-
- Hepatitis B Virus Studies 6
- Cervical Cancer and HPV Research 2
- Co-authors
- Rongshou Zheng (11 shared papers)Hongmei Zeng (9 shared papers)Jie He (7 shared papers)Wenqiang Wei (10 shared papers)Ru Chen (8 shared papers)Kexin Sun (7 shared papers)Shaoming Wang (7 shared papers)Li Li (3 shared papers)
- Journals
- Vaccines (4 papers)Vaccine (3 papers)International Journal of Cancer (2 papers)China CDC Weekly (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- ChinaUnited StatesIreland
In The Last Decade
Bingfeng Han
31 papers receiving 1.9k citations
Bingfeng Han's Hit Papers
Peers
Comparison fields: 5 of 127
- Health 164
- Oncology 362
- Cancer Research 155
- Pulmonary and Respiratory Medicine 254
- Hepatology 60
Countries citing papers authored by Bingfeng Han
This map shows the geographic impact of Bingfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfeng Han more than expected).
Fields of papers citing papers by Bingfeng Han
This network shows the impact of papers produced by Bingfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfeng Han. The network helps show where Bingfeng Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingfeng Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer incidence and mortality in China, 2022 Hit paper breakdown → | 2024 | 1073 |
| 2 | [Cancer incidence and mortality in China, 2022]. Hit paper breakdown → | 2024 | 265 |
| 3 | Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN Hit paper breakdown → | 2024 | 128 |
| 4 | 2021 | 125 | |
| 5 | Cancer survival statistics in China 2019–2021: a multicenter, population-based study Hit paper breakdown → | 2024 | 62 |
| 6 | 2024 | 35 | |
| 7 | 2018 | 28 | |
| 8 | 2019 | 26 | |
| 9 | 2024 | 20 | |
| 10 | 2022 | 16 | |
| 11 | 2024 | 16 | |
| 12 | 2020 | 14 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2025 | 11 | |
| 17 | 2021 | 9 | |
| 18 | 2023 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2021 | 6 |
About Bingfeng Han
Bingfeng Han is a scholar working on Health, Epidemiology, Infectious Diseases, Clinical Psychology and Oncology, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (9 papers), Hepatitis B Virus Studies (6 papers), COVID-19 and Mental Health (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Global Cancer Incidence and Screening (3 papers), COVID-19 epidemiological studies (2 papers), Cervical Cancer and HPV Research (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Health (164 citations), Oncology (362 citations), Cancer Research (155 citations), Pulmonary and Respiratory Medicine (254 citations) and Hepatology (60 citations). Bingfeng Han has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Rongshou Zheng, Hongmei Zeng, Jie He, Wenqiang Wei, Ru Chen, Kexin Sun, Shaoming Wang, Li Li, Shaoming Wang and Wenqiang Wei. Their work appears in journals such as Vaccines, Vaccine, International Journal of Cancer, China CDC Weekly and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.